APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Treatment of PNH

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Treatment of PNH Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174042980328 December 2025188 pages

Choose your research edition.

Industry ResearchTreatment of PNH Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Treatment of PNH Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Treatment of PNH Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Treatment of PNH Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Treatment of PNH Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Treatment of PNH market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Treatment of PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Treatment of PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Treatment of PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Treatment of PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Treatment of PNH include Alexion Pharmaceuticals, Apellis Pharmaceuticals, Samsung Bioepis, Amgen, Roche and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Treatment of PNH market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Treatment of PNH and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Treatment of PNH sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Treatment of PNH market size, projected growth trends, production technologies, key applications, and end-use industries.

Treatment of PNH Segment by Company

Alexion Pharmaceuticals

Apellis Pharmaceuticals

Samsung Bioepis

Amgen

Roche

Novartis

Treatment of PNH Segment by Type

Complement Inhibitors

Supportive Care

Others

Treatment of PNH Segment by Application

Hospital

Clinic

Other

Treatment of PNH Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment of PNH market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treatment of PNH and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment of PNH.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Treatment of PNH market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Treatment of PNH manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Treatment of PNH in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Treatment of PNH in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Treatment of PNH Industry Trends Table 2. Treatment of PNH Industry Drivers Table 3. Treatment of PNH Industry Opportunities and Challenges Table 4. Treatment of PNH Industry Restraints Table 5. Global Treatment of PNH Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Treatment of PNH Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Treatment of PNH Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Treatment of PNH Sales Market Share by Manufacturers Table 9. Global Treatment of PNH Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Treatment of PNH Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Treatment of PNH Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Treatment of PNH Manufacturers, Product Type & Application Table 13. Global Treatment of PNH Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Treatment of PNH by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Complement Inhibitors Table 17. Major Manufacturers of Supportive Care Table 18. Major Manufacturers of Others Table 19. Global Treatment of PNH Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Treatment of PNH Sales by Type (2021-2026) & (K Units) Table 21. Global Treatment of PNH Sales by Type (2027-2032) & (K Units) Table 22. Global Treatment of PNH Sales Market Share by Type (2021-2026) Table 23. Global Treatment of PNH Sales Market Share by Type (2027-2032) Table 24. Global Treatment of PNH Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Treatment of PNH Revenue by Type (2021-2026) & (K Units) Table 26. Global Treatment of PNH Revenue by Type (2027-2032) & (K Units) Table 27. Global Treatment of PNH Revenue Market Share by Type (2021-2026) Table 28. Global Treatment of PNH Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Other Table 32. Global Treatment of PNH Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Treatment of PNH Sales by Application (2021-2026) & (K Units) Table 34. Global Treatment of PNH Sales by Application (2027-2032) & (K Units) Table 35. Global Treatment of PNH Sales Market Share by Application (2021-2026) Table 36. Global Treatment of PNH Sales Market Share by Application (2027-2032) Table 37. Global Treatment of PNH Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Treatment of PNH Revenue by Application (2021-2026) & (K Units) Table 39. Global Treatment of PNH Revenue by Application (2027-2032) & (K Units) Table 40. Global Treatment of PNH Revenue Market Share by Application (2021-2026) Table 41. Global Treatment of PNH Revenue Market Share by Application (2027-2032) Table 42. Global Treatment of PNH Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Treatment of PNH Sales by Region (2021-2026) & (K Units) Table 44. Global Treatment of PNH Sales Market Share by Region (2021-2026) Table 45. Global Treatment of PNH Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Treatment of PNH Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Treatment of PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 49. North America Treatment of PNH Sales by Country (2027-2032) & (K Units) Table 50. Europe Treatment of PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 52. Europe Treatment of PNH Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Treatment of PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Treatment of PNH Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Treatment of PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Treatment of PNH Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Treatment of PNH Sales by Country (2027-2032) & (K Units) Table 59. Global Treatment of PNH Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Treatment of PNH Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Treatment of PNH Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Treatment of PNH Revenue Market Share by Region (2021-2026) Table 63. Global Treatment of PNH Revenue Market Share by Region (2027-2032) Table 64. Alexion Pharmaceuticals Company Information Table 65. Alexion Pharmaceuticals Business Overview Table 66. Alexion Pharmaceuticals Treatment of PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Alexion Pharmaceuticals Treatment of PNH Product Portfolio Table 68. Alexion Pharmaceuticals Recent Development Table 69. Apellis Pharmaceuticals Company Information Table 70. Apellis Pharmaceuticals Business Overview Table 71. Apellis Pharmaceuticals Treatment of PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Apellis Pharmaceuticals Treatment of PNH Product Portfolio Table 73. Apellis Pharmaceuticals Recent Development Table 74. Samsung Bioepis Company Information Table 75. Samsung Bioepis Business Overview Table 76. Samsung Bioepis Treatment of PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Samsung Bioepis Treatment of PNH Product Portfolio Table 78. Samsung Bioepis Recent Development Table 79. Amgen Company Information Table 80. Amgen Business Overview Table 81. Amgen Treatment of PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Amgen Treatment of PNH Product Portfolio Table 83. Amgen Recent Development Table 84. Roche Company Information Table 85. Roche Business Overview Table 86. Roche Treatment of PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Roche Treatment of PNH Product Portfolio Table 88. Roche Recent Development Table 89. Novartis Company Information Table 90. Novartis Business Overview Table 91. Novartis Treatment of PNH Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Novartis Treatment of PNH Product Portfolio Table 93. Novartis Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Treatment of PNH Distributors List Table 97. Treatment of PNH Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Treatment of PNH Product Image Figure 2. Global Treatment of PNH Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treatment of PNH Market Size (2021-2032) & (US$ Million) Figure 4. Global Treatment of PNH Sales (2021-2032) & (K Units) Figure 5. Global Treatment of PNH Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Treatment of PNH Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Complement Inhibitors Image Figure 9. Supportive Care Image Figure 10. Others Image Figure 11. Global Treatment of PNH Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Treatment of PNH Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Treatment of PNH Sales Market Share by Type (2021-2032) Figure 14. Global Treatment of PNH Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Treatment of PNH Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Treatment of PNH Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Treatment of PNH Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Treatment of PNH Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Treatment of PNH Sales Market Share by Application (2021-2032) Figure 23. Global Treatment of PNH Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Treatment of PNH Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Treatment of PNH Revenue Market Share by Application (2021-2032) Figure 26. North America Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Treatment of PNH Sales Market Share by Country (2021-2032) Figure 28. U.S. Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Treatment of PNH Sales Market Share by Country (2021-2032) Figure 33. Germany Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Treatment of PNH Sales Market Share by Country (2021-2032) Figure 40. China Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Treatment of PNH Sales Market Share by Country (2021-2032) Figure 48. Brazil Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Treatment of PNH Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Treatment of PNH Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Treatment of PNH Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Treatment of PNH Revenue (2021-2032) & (US$ Million) Figure 59. North America Treatment of PNH Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Treatment of PNH Revenue (2021-2032) & (US$ Million) Figure 61. Europe Treatment of PNH Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Treatment of PNH Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Treatment of PNH Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Treatment of PNH Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Treatment of PNH Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Treatment of PNH Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Treatment of PNH Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Complement Inhibitors
  • Supportive Care
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Alexion Pharmaceuticals
  • Apellis Pharmaceuticals
  • Samsung Bioepis
  • Amgen
  • Roche
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Treatment of PNH Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Treatment of PNH Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Treatment of PNH Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Treatment of PNH Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Treatment of PNH Market Dynamics
  1. 2.1 Treatment of PNH Industry Trends
  2. 2.2 Treatment of PNH Industry Drivers
  3. 2.3 Treatment of PNH Industry Opportunities and Challenges
  4. 2.4 Treatment of PNH Industry Restraints
3 Treatment of PNH Market by Manufacturers
  1. 3.1 Global Treatment of PNH Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Treatment of PNH Sales by Manufacturers (2021-2026)
  3. 3.3 Global Treatment of PNH Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Treatment of PNH Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Treatment of PNH Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Treatment of PNH Manufacturers, Product Type & Application
  7. 3.7 Global Treatment of PNH Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Treatment of PNH Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Treatment of PNH Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Treatment of PNH Tier 1, Tier 2, and Tier 3
4 Treatment of PNH Market by Type
  1. 4.1 Treatment of PNH Type Introduction
  2. 4.1.1 Complement Inhibitors
  3. 4.1.2 Supportive Care
  4. 4.1.3 Others
  5. 4.2 Global Treatment of PNH Sales by Type
  6. 4.2.1 Global Treatment of PNH Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Treatment of PNH Sales by Type (2021-2032)
  8. 4.2.3 Global Treatment of PNH Sales Market Share by Type (2021-2032)
  9. 4.3 Global Treatment of PNH Revenue by Type
  10. 4.3.1 Global Treatment of PNH Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Treatment of PNH Revenue by Type (2021-2032)
  12. 4.3.3 Global Treatment of PNH Revenue Market Share by Type (2021-2032)
5 Treatment of PNH Market by Application
  1. 5.1 Treatment of PNH Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Treatment of PNH Sales by Application
  6. 5.2.1 Global Treatment of PNH Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Treatment of PNH Sales by Application (2021-2032)
  8. 5.2.3 Global Treatment of PNH Sales Market Share by Application (2021-2032)
  9. 5.3 Global Treatment of PNH Revenue by Application
  10. 5.3.1 Global Treatment of PNH Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Treatment of PNH Revenue by Application (2021-2032)
  12. 5.3.3 Global Treatment of PNH Revenue Market Share by Application (2021-2032)
6 Global Treatment of PNH Sales by Region
  1. 6.1 Global Treatment of PNH Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Treatment of PNH Sales by Region (2021-2032)
  3. 6.2.1 Global Treatment of PNH Sales by Region (2021-2026)
  4. 6.2.2 Global Treatment of PNH Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Treatment of PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Treatment of PNH Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Treatment of PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Treatment of PNH Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Treatment of PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Treatment of PNH Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Treatment of PNH Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Treatment of PNH Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Treatment of PNH Revenue by Region
  1. 7.1 Global Treatment of PNH Revenue by Region
  2. 7.1.1 Global Treatment of PNH Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Treatment of PNH Revenue by Region (2021-2026)
  4. 7.1.3 Global Treatment of PNH Revenue by Region (2027-2032)
  5. 7.1.4 Global Treatment of PNH Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Treatment of PNH Revenue (2021-2032)
  8. 7.2.2 North America Treatment of PNH Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Treatment of PNH Revenue (2021-2032)
  11. 7.3.2 Europe Treatment of PNH Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Treatment of PNH Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Treatment of PNH Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Treatment of PNH Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Treatment of PNH Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alexion Pharmaceuticals
  2. 8.1.1 Alexion Pharmaceuticals Company Information
  3. 8.1.2 Alexion Pharmaceuticals Business Overview
  4. 8.1.3 Alexion Pharmaceuticals Treatment of PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alexion Pharmaceuticals Treatment of PNH Product Portfolio
  6. 8.1.5 Alexion Pharmaceuticals Recent Developments
  7. 8.2 Apellis Pharmaceuticals
  8. 8.2.1 Apellis Pharmaceuticals Company Information
  9. 8.2.2 Apellis Pharmaceuticals Business Overview
  10. 8.2.3 Apellis Pharmaceuticals Treatment of PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Apellis Pharmaceuticals Treatment of PNH Product Portfolio
  12. 8.2.5 Apellis Pharmaceuticals Recent Developments
  13. 8.3 Samsung Bioepis
  14. 8.3.1 Samsung Bioepis Company Information
  15. 8.3.2 Samsung Bioepis Business Overview
  16. 8.3.3 Samsung Bioepis Treatment of PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Samsung Bioepis Treatment of PNH Product Portfolio
  18. 8.3.5 Samsung Bioepis Recent Developments
  19. 8.4 Amgen
  20. 8.4.1 Amgen Company Information
  21. 8.4.2 Amgen Business Overview
  22. 8.4.3 Amgen Treatment of PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Treatment of PNH Product Portfolio
  24. 8.4.5 Amgen Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Treatment of PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Treatment of PNH Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Treatment of PNH Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Treatment of PNH Product Portfolio
  36. 8.6.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Treatment of PNH Value Chain Analysis
  2. 9.1.1 Treatment of PNH Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Treatment of PNH Production Mode & Process
  6. 9.2 Treatment of PNH Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Treatment of PNH Distributors
  9. 9.2.3 Treatment of PNH Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst